Cargando…

The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain

The Plasminogen Activation (PA) system was originally thought to exclusively promote the degradation of fibrin by catalyzing the conversion of plasminogen into plasmin via two serine proteinases: Tissue-type Plasminogen Activator (tPA) and Urokinase-type Plasminogen Activator (uPA). However, experim...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yepes, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700753/ https://www.ncbi.nlm.nih.gov/pubmed/30539695 http://dx.doi.org/10.2174/1389450120666181211144550

Ejemplares similares

Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
por: Merino, Paola, et al.
Publicado: (2018)

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brain
por: Merino, Paola, et al.
Publicado: (2017)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
por: Yepes, Manuel
Publicado: (2019)

Urokinase-type Plasminogen Activator Promotes Synaptic Recovery in the Ischemic Brain
por: Yepes, Manuel
Publicado: (2018)

Urokinase-type plasminogen activator promotes synaptic repair in the ischemic brain
por: Diaz, Ariel, et al.
Publicado: (2018)

The Role of Citicoline in Neuroprotection and Neurorepair in Ischemic Stroke
por: Álvarez-Sabín, José, et al.
Publicado: (2013)

The Role of Astrocytes in the Neurorepair Process
por: Chiareli, Raphaela Almeida, et al.
Publicado: (2021)

Editorial: Neurogenesis and Gliogenesis as Potential Contributors to Neurorepair After Brain Damage
por: Zepeda, Angélica, et al.
Publicado: (2022)

The plasminogen activating system in the pathogenesis of Alzheimer’s disease
por: Yepes, Manuel
Publicado: (2021)

Network-Based Approach to Identify Potential Targets and Drugs that Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke
por: Wang, Yiwei, et al.
Publicado: (2017)

9-cis retinoic acid induces neurorepair in stroke brain
por: Yu, Seong-Jin, et al.
Publicado: (2017)

Neurorepair and Regeneration of the Brain: A Decade of Bioscaffolds and Engineered Microtissue
por: Zamproni, Laura N., et al.
Publicado: (2021)

Improving Neurorepair in Stroke Brain Through Endogenous Neurogenesis-Enhancing Drugs
por: Wu, Kuo-Jen, et al.
Publicado: (2017)

S-Nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats
por: Khan, Mushfiquddin, et al.
Publicado: (2011)

Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
por: Yepes, Manuel
Publicado: (2015)

Current advances in neurotrauma research: diagnosis, neuroprotection, and neurorepair
por: Chen, Jinhui, et al.
Publicado: (2014)

Plasminogen Activators in Neurovascular and Neurodegenerative Disorders
por: Yepes, Manuel, et al.
Publicado: (2021)

Tissue-type plasminogen activator is a homeostatic regulator of synaptic function in the central nervous system
por: Jeanneret, Valerie, et al.
Publicado: (2017)

Tissue-type plasminogen activator is a modulator of the synaptic vesicle cycle
por: Yepes, Manuel
Publicado: (2016)

Immunologic Implications for Stroke Recovery: Unveiling the Role of the Immune System in Pathogenesis, Neurorepair, and Rehabilitation
por: Hey, Grace, et al.
Publicado: (2023)

Editorial: Neurorepair Strategies to Induce Angiogenesis, Neurogenesis and Synaptic Plasticity
por: Klempin, Friederike, et al.
Publicado: (2021)

Repurposing of an immunosuppressive drug holds promise for stem-cell-based neurorepair
Publicado: (2014)

Modeling Neuroregeneration and Neurorepair in an Aging Context: The Power of a Teleost Model
por: Van houcke, Jolien, et al.
Publicado: (2021)

Preterm neonatal brain injury: are human amnion epithelial stem cells a pan-treatment for neuroprotection and neurorepair?
por: Davidson, Joanne O., et al.
Publicado: (2021)

Factors Secreted by Endothelial Progenitor Cells Enhance Neurorepair Responses after Cerebral Ischemia in Mice
por: Rosell, Anna, et al.
Publicado: (2013)

Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model
por: Ye, Sining, et al.
Publicado: (2023)

Genome response to tissue plasminogen activator in experimental ischemic stroke
por: Jickling, Glen C, et al.
Publicado: (2010)

Novel C1q receptor-mediated signaling controls neural stem cell behavior and neurorepair
por: Benavente, Francisca, et al.
Publicado: (2020)

Aging impairs the essential contributions of non‐glial progenitors to neurorepair in the dorsal telencephalon of the Killifish Nothobranchius furzeri
por: Van houcke, Jolien, et al.
Publicado: (2021)

Promoting endothelial function by S-nitrosoglutathione through the HIF-1α/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in rats
por: Khan, Mushfiquddin, et al.
Publicado: (2015)

Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors
por: Rossmeisl, John H, et al.
Publicado: (2017)

Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2011)

Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
por: Ganti, Latha, et al.
Publicado: (2022)

L-Serine Treatment May Improve Neurorestoration of Rats after Permanent Focal Cerebral Ischemia Potentially Through Improvement of Neurorepair
por: Sun, Li, et al.
Publicado: (2014)

Group B Streptococcus Hijacks the Host Plasminogen System to Promote Brain Endothelial Cell Invasion
por: Magalhães, Vanessa, et al.
Publicado: (2013)

Tissue-type Plasminogen Activator (tPA) Modulates the Postsynaptic Response of Cerebral Cortical Neurons to the Presynaptic Release of Glutamate
por: Jeanneret, Valerie, et al.
Publicado: (2016)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
por: Bruce, Nhu T., et al.
Publicado: (2011)

Association of Geographical Factors With Administration of Tissue Plasminogen Activator for Acute Ischemic Stroke
por: Kunisawa, Susumu, et al.
Publicado: (2013)

Intravenous Tissue Plasminogen Activator for an Ischemic Stroke with Occult Double Primary Cancer
por: Yoneda, Yukihiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p5raa44r7a2lke8cenb4qbpos2